295739
Associations between Medical Risk Factors and 2007-2009 Infant Mortality among White and Black Singletons in the United States
Methods: Birth outcomes and information on infant, maternal, and medical risk factors by county is extracted from 2007-2009 period linked birth/infant death CDC datasets and merged with the 2008 American Community Survey data by County. Multilevel logistic regression is used to quantify county-level variations in infant mortality. Fixed-effects logistic regression and survival analysis further examine contributing factors to racial disparities in infant mortality.
Results: Preliminary analysis showed racial disparities in some risk factors; non-Hispanic Black singletons born at advanced maternal age were associated with lower risk of infant mortality while the results weren't significant for non-Hispanic White singletons. Among 199 counties (population≥ 250,000) used in the analysis, Baltimore County, MD had the highest 3-year infant mortality rate (1.006%). Pairwise correlation analysis showed that county-level infant mortality rates were significantly associated with White/Black population ratio (¦Ñ=-0.588).
Discussion: It's necessary to understand the contribution of risk factors. Identifying counties with the greatest difference in infant mortality rates allows for targeted interventions to the areas in most need.
Learning Areas:
Biostatistics, economicsEpidemiology
Learning Objectives:
Identify medical and social risk factors for infant mortality among non-Hispanic White and non-Hispanic Black singletons in the United States using a series of simple logistic regression analyses.
Explore racial disparities in infant mortality through fixed-effects logistic regression.
Assess county-level racial disparities in infant mortality.
Qualified on the content I am responsible for because: I conducted the research to be presented
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.